Tuesday 24 June 2014

Update to my what's missing from AbbVie's £27 billion takeover bid for Shire story?

The odds on Lazard turning up as an adviser to a bidder for Shire appear to be improving after it emerged the FTSE-100 listed company has appointed Goldman Sachs to its defence advisory team.

(This comment will only make sense if you read yesterday's Betaville piece: http://betaville123.blogspot.co.uk/2014/06/whats-missing-from-abbvies-27-billion.html)

Anyway, here is a link to the detailed New York Times article, which revealed last night Shire's appointment of Goldman Sachs to the Shire advisory team: http://dealbook.nytimes.com/2014/06/23/shire-said-to-hire-goldman-sachs-as-an-adviser/?_php=true&_type=blogs&_r=0.

No comments:

Post a Comment